600 related articles for article (PubMed ID: 8923861)
1. Metabolic effects of metformin on glucose and lactate metabolism in noninsulin-dependent diabetes mellitus.
Cusi K; Consoli A; DeFronzo RA
J Clin Endocrinol Metab; 1996 Nov; 81(11):4059-67. PubMed ID: 8923861
[TBL] [Abstract][Full Text] [Related]
2. Acute antihyperglycemic mechanisms of metformin in NIDDM. Evidence for suppression of lipid oxidation and hepatic glucose production.
Perriello G; Misericordia P; Volpi E; Santucci A; Santucci C; Ferrannini E; Ventura MM; Santeusanio F; Brunetti P; Bolli GB
Diabetes; 1994 Jul; 43(7):920-8. PubMed ID: 8013758
[TBL] [Abstract][Full Text] [Related]
3. Metabolic effects of metformin in non-insulin-dependent diabetes mellitus.
Stumvoll M; Nurjhan N; Perriello G; Dailey G; Gerich JE
N Engl J Med; 1995 Aug; 333(9):550-4. PubMed ID: 7623903
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects.
DeFronzo RA; Barzilai N; Simonson DC
J Clin Endocrinol Metab; 1991 Dec; 73(6):1294-301. PubMed ID: 1955512
[TBL] [Abstract][Full Text] [Related]
5. Contribution of obesity to defects of intracellular glucose metabolism in NIDDM.
Chung JW; Suh KI; Joyce M; Ditzler T; Henry RR
Diabetes Care; 1995 May; 18(5):666-73. PubMed ID: 8586004
[TBL] [Abstract][Full Text] [Related]
6. The effects of metformin on glycemic control and serum lipids in insulin-treated NIDDM patients with suboptimal metabolic control.
Robinson AC; Burke J; Robinson S; Johnston DG; Elkeles RS
Diabetes Care; 1998 May; 21(5):701-5. PubMed ID: 9589227
[TBL] [Abstract][Full Text] [Related]
7. Glucose and lipid metabolism in non-insulin-dependent diabetes. Effect of metformin.
Riccio A; Del Prato S; Vigili de Kreutzenberg S; Tiengo A
Diabete Metab; 1991 May; 17(1 Pt 2):180-4. PubMed ID: 1936473
[TBL] [Abstract][Full Text] [Related]
8. Oral vanadyl sulfate improves insulin sensitivity in NIDDM but not in obese nondiabetic subjects.
Halberstam M; Cohen N; Shlimovich P; Rossetti L; Shamoon H
Diabetes; 1996 May; 45(5):659-66. PubMed ID: 8621019
[TBL] [Abstract][Full Text] [Related]
9. Metformin normalizes nonoxidative glucose metabolism in insulin-resistant normoglycemic first-degree relatives of patients with NIDDM.
Widén EI; Eriksson JG; Groop LC
Diabetes; 1992 Mar; 41(3):354-8. PubMed ID: 1551495
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.
DeFronzo RA; Goodman AM
N Engl J Med; 1995 Aug; 333(9):541-9. PubMed ID: 7623902
[TBL] [Abstract][Full Text] [Related]
11. Improved insulin action and glycemic control after long-term angiotensin-converting enzyme inhibition in subjects with arterial hypertension and type II diabetes.
Torlone E; Britta M; Rambotti AM; Perriello G; Santeusanio F; Brunetti P; Bolli GB
Diabetes Care; 1993 Oct; 16(10):1347-55. PubMed ID: 8269792
[TBL] [Abstract][Full Text] [Related]
12. Glucose-mediated glucose disposal in insulin-resistant normoglycemic relatives of type 2 diabetic patients.
Henriksen JE; Levin K; Thye-Rønn P; Alford F; Hother-Nielsen O; Holst JJ; Beck-Nielsen H
Diabetes; 2000 Jul; 49(7):1209-18. PubMed ID: 10909980
[TBL] [Abstract][Full Text] [Related]
13. Studies on the mass action effect of glucose in NIDDM and IDDM: evidence for glucose resistance.
Del Prato S; Matsuda M; Simonson DC; Groop LC; Sheehan P; Leonetti F; Bonadonna RC; DeFronzo RA
Diabetologia; 1997 Jun; 40(6):687-97. PubMed ID: 9222649
[TBL] [Abstract][Full Text] [Related]
14. Different sensitivity of glucose and amino acid metabolism to insulin in NIDDM.
Luzi L; Petrides AS; De Fronzo RA
Diabetes; 1993 Dec; 42(12):1868-77. PubMed ID: 8243833
[TBL] [Abstract][Full Text] [Related]
15. Multiple defects of both hepatic and peripheral intracellular glucose processing contribute to the hyperglycaemia of NIDDM.
Vaag A; Alford F; Henriksen FL; Christopher M; Beck-Nielsen H
Diabetologia; 1995 Mar; 38(3):326-36. PubMed ID: 7758880
[TBL] [Abstract][Full Text] [Related]
16. Lipolysis and gluconeogenesis from glycerol are increased in patients with noninsulin-dependent diabetes mellitus.
Puhakainen I; Koivisto VA; Yki-Järvinen H
J Clin Endocrinol Metab; 1992 Sep; 75(3):789-94. PubMed ID: 1517368
[TBL] [Abstract][Full Text] [Related]
17. Insulin inhibition of overnight glucose production and gluconeogenesis from lactate in NIDDM.
Yki-Järvinen H; Helve E; Sane T; Nurjhan N; Taskinen MR
Am J Physiol; 1989 Jun; 256(6 Pt 1):E732-9. PubMed ID: 2660587
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of lipolysis decreases lipid oxidation and gluconeogenesis from lactate but not fasting hyperglycemia or total hepatic glucose production in NIDDM.
Puhakainen I; Yki-Järvinen H
Diabetes; 1993 Dec; 42(12):1694-9. PubMed ID: 8243814
[TBL] [Abstract][Full Text] [Related]
19. Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance.
Groop LC; Bonadonna RC; DelPrato S; Ratheiser K; Zyck K; Ferrannini E; DeFronzo RA
J Clin Invest; 1989 Jul; 84(1):205-13. PubMed ID: 2661589
[TBL] [Abstract][Full Text] [Related]
20. Metformin improves peripheral but not hepatic insulin action in obese patients with type II diabetes.
Hother-Nielsen O; Schmitz O; Andersen PH; Beck-Nielsen H; Pedersen O
Acta Endocrinol (Copenh); 1989 Mar; 120(3):257-65. PubMed ID: 2648723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
